Korean biotech ETFs Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
13:30
Apr 22
Apr 22
Biotech ETF outflows create vicious cycle.
Biotech ETF flows are negative: one bad event can hurt biotech sentiment, redemptions from biotech ETFs force selling of their holdings, and the resulting weakness in constituents can feed further ETF selling. The speaker agrees this is creating a vicious cycle in Korean biotech ETFs.
HIGH
03:01
Apr 20
Apr 20
Biotech ETF flows create virtuous cycle.
The speaker sees a virtuous cycle in Korean biotech: as biotech ETFs rebalance, they must keep buying bio stocks, and strong clinical announcements from Alginomics, Olix, Voronoi and others improve sentiment. That ETF flow and sentiment feedback can support the group even though biotech is psychologically driven and dangerous when the mood turns.
MED
23:22
Apr 07
Apr 07
KOSDAQ biotech ETFs face event risk
KOSDAQ and biotech ETFs carry high weights in event-driven biotech and future-value names, such as Samchundang Pharmaceutical, Alteogen, HLB, and Rainbow Robotics; this concentration makes them vulnerable to single-stock shocks, as seen when TIGER KOSDAQ 150 Biotech had a 12% weight in Samchundang Pharmaceutical and suffered a sharp weekly decline.
MED
About Korean biotech ETFs Investor Commentary
Across the available history and selected sources, Buzzberg tracks Korean biotech ETFs across 2 sources: 1 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 33% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Latest voices: Choi Chang-gyu, Lee Kwon-hee, Kwon Soon-woo.